Cero Therapeutics (CERO) announced its board of directors has appointed Chris Ehrlich as CEO. Previously he held the position of interim CEO. In addition to his role at Cero, he currently serves as CEO of Launch One Acquisition Corporation (LPAA).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERO: